Dosing & administration

The following information is intended for licensed veterinarians only. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.


How to appropriately administer BetaVet.®

  • Shake well immediately before use
  • Using strict aseptic technique, administer BetaVet® (betamethasone sodium phosphate and betamethasone acetate injectable suspension) 1.5 mL (9 mg total betamethasone) per joint by intra-articular (IA) injection
  • May be administered concurrently in up to 2 joints per horse
  • Use immediately after opening; discard any remaining contents
BetaVet veterinary horse leg

PRECAUTIONS: Corticosteroids, including BetaVet®, administered intra-articularly are systemically absorbed. Do not use in horses with acute infections.

Advantages of BetaVet® over compounded injectable corticosteroids.1

  • FDA-approved for use in horses
  • Safety and efficacy backed by clinical studies
  • Consistency in product quality and potency
  • Product stability proven to ensure consistent safety and efficacy over the entire shelf life

An FDA-approved drug, BetaVet® also supports quality care and fosters veterinary-client relationships.

Are you familiar with the other advantages of an FDA-approved treatment? The following information is for licensed veterinarians only.

BetaVet® (betamethasone sodium phosphate and betamethasone acetate injectable suspension)
For Intra-articular (I.A.) use in Horses.
INDICATIONS: BetaVet® (betamethasone sodium phosphate and betamethasone acetate injectable suspension) is indicated for the control of pain and inflammation associated with osteoarthritis in horses.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS: BetaVet® is contraindicated in horses with hypersensitivity to betamethasone. Intra-articular injection of corticosteroids for local effect is contraindicated in the presence of septic arthritis. WARNINGS: Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted congenital anomalies. Before use of corticosteroids in pregnant animals, the possible benefits should be weighed against potential hazards. Human Warnings: Not for use in humans. Keep this and all medications out of the reach of children. PRECAUTIONS: Corticosteroids, including BetaVet®, administered intra-articularly are systemically absorbed. Do not use in horses with acute infections. Acute moderate to severe exacerbation of pain, further loss of joint motion, fever, or malaise within several days following intra-articular injection may indicate a septic process. Because of the anti-inflammatory action of corticosteroids, signs of infection in the treated joint may be masked. Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution in horses with a history of laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis, equine pituitary pars intermedia dysfunction (PPID), and congestive heart failure. Concurrent use of other anti-inflammatory drugs should be approached with caution. Consider appropriate wash out times prior to administering additional NSAIDs or corticosteroids. ADVERSE REACTIONS: Adverse reactions reported during a field study of 239 horses of various breeds which had been administered either BetaVet® (n=119) or a saline control (n=120) at five percent (5%) and above were: acute joint effusion and/or local injection site swelling (within 2 days of injection), 15% BetaVet® and 13% saline control; increased lameness (within the first 5 days), 6.7% BetaVet® and 8.3% saline control; loose stool, 5.9% BetaVet® and 8.3% saline control; increased heat in joint, 2.5% BetaVet® and 5% saline control; and depression, 5.9% BetaVet® and 1.6% saline control.
SHAKE WELL IMMEDIATELY BEFORE USE. For additional safety information, please see full prescribing information.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
1. BetaVet® Package Insert, Rev 1/19.

Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

EQUINE VETERINARY
PROFESSIONAL
HORSE OWNER
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands